Taiwan's Academia Sinica team produces Omicron-specific vaccine

A team of researchers from Taiwan's Academia Sinica has developed a series of next-generation vaccines that early results show could be highly effective against the Omicron variant of COVID-19 as well as new mutations of the disease.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)